These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8912457)

  • 1. Effect of whole blood storage on factor VIII recovery in fresh frozen plasma and cryoprecipitate.
    Allersma DP; Imambaks RM; Meerhof LJ
    Vox Sang; 1996; 71(3):150-4. PubMed ID: 8912457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of factor VIII and factor IX in fresh-frozen plasma produced from whole blood stored at 4 °C overnight in Turkey.
    Agus N; Yilmaz N; Colak A; Liv F
    Blood Transfus; 2012 Apr; 10(2):191-3. PubMed ID: 22153689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight storage of whole blood: a comparison of two designs of butane-1,4-diol cooling plates.
    van der Meer PF; Pietersz RN
    Transfusion; 2007 Nov; 47(11):2038-43. PubMed ID: 17958532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions to the optimal use of human blood. VIII. Stability of blood coagulation factor VII during collection and storage of whole blood and plasma.
    Vermeer C; Soute BA; Ates G; Hellings JA; Brummelhuis HG
    Vox Sang; 1976; 31(1 SUPPL):55-67. PubMed ID: 12616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.
    Omidkhoda A; Tabatabaei MR; Atarodi K; Karimi K; Froushani AR; Pourfathollah AA
    Blood Transfus; 2011 Oct; 9(4):394-9. PubMed ID: 21839017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C; Soute BA; Ates G; Brummelhuis HG
    Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage of whole blood for up to 24 hours at ambient temperature prior to component preparation.
    Pietersz RN; de Korte D; Reesink HW; Dekker WJ; van den Ende A; Loos JA
    Vox Sang; 1989; 56(3):145-50. PubMed ID: 2499118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible advantages of cryoprecipitate prepared from fresh frozen plasma from blood stored for 24 hours.
    Philip J; Kumarage S; Chatterjee T; Kumar S; Mallhi R
    Lab Med; 2014; 45(2):111-5. PubMed ID: 24868990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of factor VIII recovery in cryoprecipitate.
    Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
    Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of storing whole blood at 22 degrees C for up to 24 hours with and without rapid cooling on the quality of red cell concentrates and fresh-frozen plasma.
    Wilsher C; Garwood M; Sutherland J; Turner C; Cardigan R
    Transfusion; 2008 Nov; 48(11):2338-47. PubMed ID: 18657079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.